Amphotericin B: liposomal less costly than lipid complex Clinical study 01 February 2014 Pages: 3 - 3
Cervical cancer prevention cost effective in developing countries Clinical study 01 February 2014 Pages: 3 - 3
Examining drug reimbursement decision-making in the OECD Clinical study 01 February 2014 Pages: 4 - 4
Early detection of brain metastases by surveillance MRI cost saving Clinical study 01 February 2014 Pages: 4 - 4
Injectable therapy in T2DM: real-world outcomes and costs Clinical study 01 February 2014 Pages: 5 - 5
Is bortezomib cost effective in induction prior to ASCT in MM? Clinical study 01 February 2014 Pages: 5 - 5
Is enoxaparin cost effective in pregnant women with SCD? Clinical study 01 February 2014 Pages: 6 - 6
Mammostrat genotyping worth considering for early-stage BC Clinical study 01 February 2014 Pages: 6 - 6
Optimising acute stroke care for thrombolysis saves costs Clinical study 01 February 2014 Pages: 7 - 7
Nucleic acid amplification "highly sensitive and efficient" for BC Clinical study 01 February 2014 Pages: 7 - 7
Navigated intervention for CRC screening effective but costly Clinical study 01 February 2014 Pages: 7 - 7
No effect of supplemental coverage on spending in cancer patients Clinical study 01 February 2014 Pages: 7 - 7
Perjeta-Herceptin combo pack now funded in Alberta, Canada Media release 01 February 2014 Pages: 10 - 10
Use of decision aids for patients − potential savings questionable Non-clinical study 01 February 2014 Pages: 10 - 10